Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Journal of Pharmacology and PharmacotherapeuticsNOW IN
    Article

    Clofazimine‑induced premaculopathy in a vitiliginous patient

    Nirupama Kasturi1★, Renuka Srinivasan1★ Corresponding author

    1. 1Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Case Report.

    CORRESPONDENCE

    Nirupama Kasturi

    Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Case Report.

    kasturiniru@gmail.com

    Received: 28-04-2016; Revised: 09-07-2016; Accepted: 15-07-2016.

    Volume 7, Issue 3 · pp. 149–151 · PUBLISHED 2016 · DOI: 10.4103/0976-500X.189685

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    A 26‑year‑old male vitiliginous patient presented with decreased visual acuity because of a central scotoma in the left eye with no significant retinal changes on fundus examination. In this case report, a diagnosis of possible drug‑induced premaculopathy was made, and the drugs were withdrawn. On the follow‑up, after 3 months, the visual acuity in the left eye gradually improved. Early suspicion of drug‑induced maculopathy and withdrawal of the drug may prevent the progression of maculopathy.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Kasturi, N., & Srinivasan, R. (2016). Clofazimine‑induced premaculopathy in a vitiliginous patient. Journal of Pharmacology and Pharmacotherapeutics, 7(3), 149–151. https://doi.org/10.4103/0976-500X.189685